Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
The enzyme, PEG-KYNase, does not directly kill cancer cells but instead empowers the immune system to eradicate unwanted cells on its own. PEG-KYNase is designed to degrade kynurenine, a metabolite produced by numerous tumors that … Read the rest »
AUSTIN, Texas — A team of chemical engineers at The University of Texas at Austin has developed a new, cost-effective method for synthetically producing a biorenewable platform chemical called triacetic acid lactone (TAL) that can be used to produce innovative new drugs and sustainable plastics at an industrial scale, as described this week in Proceedings … Read the rest »
Researchers in the Cockrell School of Engineering and the College of Natural Sciences at The University of Texas at Austin have received a $15.6 million grant from the National Science Foundation (NSF) to discover and advance new types of materials for use in many applications including energy storage, medical devices and information processing. … Read the rest »
Engineers in the McKetta Department of Chemical Engineering at The University of Texas at Austin have been selected to help lead a five-year, $20 million National Science Foundation engineering research center aimed at developing new mobile technologies for converting natural gas into transportation fuels near rural natural gas sites.
The ability to convert natural gas … Read the rest »
The trade-off between membrane permeability and selectivity
Current studies on membrane permeability and selectivity show that improvements in the field could positively impact water filtration, treatment of waste products from fracking, and even climate change. But what challenges do engineers face when it comes to membranes? And what needs to be considered to make strides … Read the rest »
An algorithm based on levels of metabolites found in a blood sample can accurately predict whether a child is on the Autism spectrum of disorder (ASD), based upon a recent study. The algorithm, developed by Texas ChE alumnus Juergen Hahn (Ph.D. ’02) and researchers at Rensselaer Polytechnic Institute, is the first physiological test for … Read the rest »
A research team led by Texas ChE Professor George Georgiou has engineered an enzyme that safely treats prostate and breast cancer in animals and also lengthens the lifespan of models that develop chronic lymphocytic leukemia. The new treatment and results from preclinical trials are described in a paper published in the Nov. 21 issue of … Read the rest »